Amanta Healthcare Limited has informed the Exchange regarding 'Open Market Purchase of Equity Shares by Immediate Relative of Director'.
AMANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amanta Healthcare has disclosed that Ms. Dympal Jain, the immediate relative of Director Shri Nitin Jain, purchased 15,675 equity shares of the company through open market transactions between March 19 and March 24, 2026. The disclosure was filed under SEBI's Prohibition of Insider Trading Regulations (Regulation 7(2) read with 6(2)) via Form C dated March 25, 2026. The shares were bought on the stock exchanges (BSE scrip code 544502, NSE symbol AMANTA). The transaction is routine insider trading compliance reporting, indicating a director's family member is accumulating shares in the company.
This is a modest insider buy by a director's immediate relative, generally seen as a mild positive signal suggesting family confidence in the company's prospects. The 15,675-share purchase is small in scale, so it is unlikely to move the stock price meaningfully, but it adds to insider ownership.